Insider Selling: Viemed Healthcare (NASDAQ:VMD) President Sells 65,000 Shares of Stock
by Amy Steele · The Cerbat GemViemed Healthcare, Inc. (NASDAQ:VMD – Get Free Report) President Michael Moore sold 65,000 shares of the firm’s stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $8.77, for a total value of $570,050.00. Following the transaction, the president owned 1,585,812 shares of the company’s stock, valued at approximately $13,907,571.24. The trade was a 3.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Michael Moore also recently made the following trade(s):
- On Thursday, March 19th, Michael Moore sold 40,232 shares of Viemed Healthcare stock. The stock was sold at an average price of $9.21, for a total value of $370,536.72.
- On Wednesday, March 18th, Michael Moore sold 31,570 shares of Viemed Healthcare stock. The shares were sold at an average price of $9.42, for a total value of $297,389.40.
Viemed Healthcare Price Performance
NASDAQ VMD traded down $0.51 during trading on Friday, hitting $8.71. 703,686 shares of the stock traded hands, compared to its average volume of 245,033. The company has a quick ratio of 1.06, a current ratio of 1.18 and a debt-to-equity ratio of 0.08. Viemed Healthcare, Inc. has a 12-month low of $5.93 and a 12-month high of $10.06. The firm has a 50-day simple moving average of $8.30 and a 200-day simple moving average of $7.37. The company has a market capitalization of $336.21 million, a P/E ratio of 23.54 and a beta of 1.23.
Viemed Healthcare (NASDAQ:VMD – Get Free Report) last posted its earnings results on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.12 by $0.02. Viemed Healthcare had a return on equity of 10.72% and a net margin of 5.53%.The firm had revenue of $76.18 million during the quarter, compared to the consensus estimate of $77.70 million.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the stock. Zacks Research upgraded shares of Viemed Healthcare to a “hold” rating in a research report on Thursday, January 8th. Wall Street Zen upgraded Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Viemed Healthcare in a research report on Monday, December 29th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.
Get Our Latest Report on Viemed Healthcare
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the company. Intech Investment Management LLC increased its position in Viemed Healthcare by 14.4% during the second quarter. Intech Investment Management LLC now owns 18,612 shares of the company’s stock valued at $129,000 after acquiring an additional 2,349 shares during the last quarter. Martingale Asset Management L P lifted its holdings in shares of Viemed Healthcare by 6.0% in the 4th quarter. Martingale Asset Management L P now owns 42,483 shares of the company’s stock worth $316,000 after acquiring an additional 2,399 shares during the last quarter. Invesco Ltd. boosted its stake in shares of Viemed Healthcare by 17.1% during the 4th quarter. Invesco Ltd. now owns 21,773 shares of the company’s stock worth $162,000 after purchasing an additional 3,173 shares during the period. State of Alaska Department of Revenue purchased a new position in shares of Viemed Healthcare during the 4th quarter worth about $25,000. Finally, Barclays PLC grew its holdings in Viemed Healthcare by 2.7% during the 4th quarter. Barclays PLC now owns 131,759 shares of the company’s stock valued at $979,000 after purchasing an additional 3,480 shares during the last quarter. 74.24% of the stock is owned by hedge funds and other institutional investors.
About Viemed Healthcare
Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.